- Home
- PEG vs BDX Comparison
PEG vs BDX Comparison
Compare PEG & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEG | BDX |
|---|---|---|
| Founded | 1903 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6B | 43.0B |
| IPO Year | 1994 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PEG | BDX |
|---|---|---|
| Price | $77.25 | $153.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $92.79 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 2.4M | 2.3M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.37% | 2.89% |
| EPS Growth | ★ 19.21 | N/A |
| EPS | ★ 1.48 | 0.25 |
| Revenue | $12,168,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $4.89 | N/A |
| Revenue Next Year | $4.16 | $3.02 |
| P/E Ratio | ★ $52.45 | $621.72 |
| Revenue Growth | ★ 18.25 | 8.24 |
| 52 Week Low | $76.05 | $140.11 |
| 52 Week High | $91.26 | $213.08 |
Technical Indicators
Market Signals| Indicator | PEG | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 51.82 |
| Support Level | N/A | $153.27 |
| Resistance Level | $81.50 | $159.72 |
| Average True Range (ATR) | 1.48 | 3.98 |
| MACD | -0.49 | 0.08 |
| Stochastic Oscillator | 8.16 | 36.15 |
Price Performance
Historical ComparisonAbout PEG Public Service Enterprise Group Incorporated
Public Service Enterprise Group is the holding company for a regulated utility (PSE&G) and PSEG Power, which owns all or a share of three nuclear plants and clean energy projects. PSE&G provides regulated gas and electricity delivery services in New Jersey to a combined 4.3 million customers. Public Service Enterprise Group also operates the Long Island Power Authority system under a contract extension through 2030. In 2022, the company sold its gas and oil power plants in the mid-Atlantic, New York, and the Northeast.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.